Skip to main content
OpenTrials

Clinical trial condition

Spondylarthropathies

Explore clinical trials studying Spondylarthropathies. Study availability and eligibility vary by location and protocol.

825 public trials 129 recruiting studies
Refine in advanced search Browse all conditions

Spondylarthropathies trial results

Completed

Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes

NCT02469753

Conditions
Ankylosing Spondylitis, Ankylosis, Arthritis, +9 more
Locations
  • Service de rhumatologie - CHU d'Amiens Amiens, France
  • Service de rhumatologie - CHU de Besançon Besançon, France
  • Service de Rhumatologie - CHU de Bordeaux Bordeaux, France
  • service de rhumatologie - AP-HP - Hôpital Ambroise Paré Boulogne-Billancourt, France
View all 22 locations
View Trial Details
Completed

Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight

NCT06588296

Conditions
Arthritis, Arthritis, Psoriatic, Body Weight, +19 more
Locations
  • AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Avondale Avondale, Arizona, United States
  • AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Chandler Chandler, Arizona, United States
  • AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Flagstaff Flagstaff, Arizona, United States
  • AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Gilbert Gilbert, Arizona, United States
View all 86 locations
View Trial Details
Completed

Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis

NCT04433442

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations
  • Inje University - Busan Paik Hospital /ID# 238911 Busan, Busan Gwang Yeogsi, South Korea
  • Inje University Haeundae Hospital /ID# 238933 Busan, Busan Gwang Yeogsi, South Korea
  • Pusan National University Hospital /ID# 238896 Busan, Busan Gwang Yeogsi, South Korea
  • Dankook University Hospital /ID# 223995 Cheonan-si, Chungcheongnam-do, South Korea
View all 63 locations
View Trial Details
Completed

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03410992

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +13 more
Locations
  • Ps0013 919 San Diego, California, United States
  • Ps0013 955 San Diego, California, United States
  • Ps0013 967 Santa Monica, California, United States
  • Ps0013 928 Fort Myers, Florida, United States
View all 77 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03370133

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +13 more
Locations
  • Ps0009 946 Phoenix, Arizona, United States
  • Ps0009 910 Bakersfield, California, United States
  • Ps0009 919 San Diego, California, United States
  • Ps0009 906 Boca Raton, Florida, United States
View all 105 locations
View Trial Details
Completed

Efficacy and Safety Study of Secukinumab in Chinese Participants With Non-radiographic Axial Spondyloarthritis

NCT04732117

Conditions
Ankylosis, Arthritis, Axial Spondyloarthritis, +9 more
Locations
  • Novartis Investigative Site Hefei, Anhui, China
  • Novartis Investigative Site Hefei, Anhui, China
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Xiamen, Fujian, China
View all 29 locations
View Trial Details

Related conditions